ADC Therapeutics SA Par Value Per Share
ADC Therapeutics SA (ADCT) had Par Value Per Share of 0.08 CHF/shares as of 2022-12-31, per its 20-F filed 2023-03-15.
Discontinued › Notes › Per Share
ifrs-full:ParValuePerShare · last filed 2023-03-15
- 2020-12-31: Par Value Per Share 0.08 CHF.
- 2020-12-29: Par Value Per Share 0.08 CHF.
- 2020-12-16: Par Value Per Share 0.08 CHF.
- 2020-12-14: Par Value Per Share 0.08 CHF.
CHF
| Period end | Par Value Per Share |
|---|---|
| 2020-12-31 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-12-29 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-12-16 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-12-14 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-09-30 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-05-19 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-04-24 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2020-04-16 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2019-12-16 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2019-09-02 | 0.08 CHF 20-F · filed 2021-03-18 |
| 2019-07-05 | 0.01 CHF 20-F · filed 2021-03-18 |
| 2019-06-14 | 0.01 CHF 20-F · filed 2021-03-18 |
| 2019-06-07 | 0.01 CHF 20-F · filed 2021-03-18 |
| 2019-02-06 | 0.01 CHF 20-F · filed 2021-03-18 |
| 2018-12-18 | 0.08 CHF 20-F · filed 2021-03-18 |
USD/shares
| Period end | Par Value Per Share |
|---|---|
| 2021-04-01 | $0.08 20-F · filed 2022-03-17 |
| 2020-09-30 | $0.08 20-F · filed 2023-03-15 |
| 2020-09-28 | $34.00 20-F · filed 2023-03-15 |
| 2020-05-19 | $19.00 20-F · filed 2023-03-15 |
| 2020-04-15 | $18.75 20-F · filed 2023-03-15 |
CHF/shares
| Period end | Par Value Per Share | Par Value Per Share as first filed |
|---|---|---|
| 2022-12-31 | 0.08 CHF/shares 20-F · filed 2023-03-15 | |
| 2022-11-01 | 0.08 CHF/shares 20-F · filed 2023-03-15 | |
| 2021-12-31 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2021-04-01 | 0.01 CHF/shares 20-F · filed 2023-03-15 | |
| 2020-12-31 | 0.08 CHF/shares 20-F · filed 2023-03-15 | |
| 2020-12-29 | 0.08 CHF/shares 20-F · filed 2021-03-18 | |
| 2020-12-16 | 0.08 CHF/shares 20-F · filed 2021-03-18 | |
| 2020-12-14 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2020-09-30 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2020-05-19 | 0.01 CHF/shares 20-F · filed 2023-03-15 | 0.08 CHF/shares 20-F · filed 2021-03-18 |
| 2020-04-24 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2020-04-16 | 0.01 CHF/shares 20-F · filed 2023-03-15 | 0.08 CHF/shares 20-F · filed 2021-03-18 |
| 2019-12-16 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2019-09-02 | 0.08 CHF/shares 20-F · filed 2022-03-17 | |
| 2019-07-05 | 0.01 CHF/shares 20-F · filed 2022-03-17 | |
| 2019-06-14 | 0.01 CHF/shares 20-F · filed 2022-03-17 | |
| 2019-06-07 | 0.01 CHF/shares 20-F · filed 2022-03-17 | |
| 2019-02-06 | 0.01 CHF/shares 20-F · filed 2022-03-17 | |
| 2018-12-18 | 0.08 CHF/shares 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |